Follow the 펨토바이오메드 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 펨토바이오메드 has logged 27 public disclosures. The latest transaction was reported on 6 November 2025 (Purchase). Among the most active insiders: 이상현. Every trade is accessible without an account.
27
Insider Decl.
n/a
Thresholds
n/a
8 ops.
Buy Volume
n/a
15 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
펨토바이오메드 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions to enhance healthcare.